Literature DB >> 15599766

A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia.

Samuel Canizales-Quinteros1, Carlos A Aguilar-Salinas, Adriana Huertas-Vázquez, María L Ordóñez-Sánchez, Maribel Rodríguez-Torres, José L Venturas-Gallegos, Laura Riba, Salvador Ramírez-Jimenez, Rocío Salas-Montiel, Giovani Medina-Palacios, Ludivina Robles-Osorio, Angel Miliar-García, Luis Rosales-León, Blanca H Ruiz-Ordaz, Alejandro Zentella-Dehesa, Adrian Ferré-D'Amare, Francisco J Gómez-Pérez, Ma Teresa Tusié-Luna.   

Abstract

Autosomal recessive hypercholesterolemia (ARH) is characterized by elevated LDL serum levels, xanthomatosis, and premature coronary artery disease. Three loci have been described for this condition (1p35, 15q25-q26 and 13q). Recently, the responsible gene at the 1p35 locus, encoding an LDL receptor adaptor protein (ARH) has been identified. We studied a Mexican ARH family with two affected siblings. Sequence analysis of the ARH gene (1p35 locus) revealed that the affected siblings are homozygous for a novel mutation (IVS4+2T>G) affecting the donor splice site in intron 4, whereas both the parents and an unaffected sister are heterozygous for this mutation. The IVS4+2T>G mutation results in a major alternative transcript derived from a cryptic splice site, which carries an in-frame deletion of 78 nucleotides in the mature mRNA. The translation of this mRNA yields a mutant protein product (ARH-26) lacking 26 amino acids, resulting in the loss of beta-strands beta6 and beta7 from the PTB domain. This is the first case where a naturally occurring mutant with an altered PTB domain has been identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599766     DOI: 10.1007/s00439-004-1192-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  A splice mutation in a Syrian autosomal recessive hypercholesterolemia family causes a two-nucleotide deletion of mRNA.

Authors:  Hussam Al-Kateb; Ekkehard K F Bautz; Friedrich C Luft; Sylvia Bähring
Journal:  Circ Res       Date:  2003-09-05       Impact factor: 17.367

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

Review 4.  Surprising similarities in structure comparison.

Authors:  J F Gibrat; T Madej; S H Bryant
Journal:  Curr Opin Struct Biol       Date:  1996-06       Impact factor: 6.809

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery.

Authors:  Sanjay K Mishra; Simon C Watkins; Linton M Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

7.  Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia.

Authors:  G Zuliani; M Arca; A Signore; G Bader; S Fazio; M Chianelli; S Bellosta; F Campagna; A Montali; M Maioli; A Pacifico; G Ricci; R Fellin
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

8.  Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis.

Authors:  Marcello Arca; Giovanni Zuliani; Kenneth Wilund; Filomena Campagna; Renato Fellin; Stefano Bertolini; Sebastiano Calandra; Giorgio Ricci; Nicola Glorioso; Mario Maioli; Paolo Pintus; Ciriaco Carru; Fausto Cossu; Jonathan Cohen; Helen H Hobbs
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

9.  Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.

Authors:  L Havekes; E de Wit; J G Leuven; E Klasen; G Utermann; W Weber; U Beisiegel
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

10.  Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1.

Authors:  Emily R Eden; Dilipkumar D Patel; Xi-Ming Sun; Jemima J Burden; Michael Themis; Matthew Edwards; Philip Lee; Clare Neuwirth; Rossitza P Naoumova; Anne K Soutar
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

View more
  5 in total

1.  Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail.

Authors:  Hay Dvir; Mehul Shah; Enrico Girardi; Lixia Guo; Marilyn G Farquhar; Dirk M Zajonc
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 2.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

3.  Familial hypercholesterolemia: the lipids or the genes?

Authors:  Akl C Fahed; Georges M Nemer
Journal:  Nutr Metab (Lond)       Date:  2011-04-22       Impact factor: 4.169

Review 4.  Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management.

Authors:  Eun-Gyong Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31

5.  A Novel Splice Site Variant in the LDLRAP1 Gene Causes Familial Hypercholesterolemia

Authors:  Najmeh Ahangari; Amirhossein Sahebkar; Mohsen Azimi-Nezhad; Hamideh Ghazizadeh; Mohsen Moohebati; Mahmoud Ebrahim; Habibollah Esmaeili; Gordon A Ferns; Alireza Pasdar; Majid Ghayour Mobarhan
Journal:  Iran Biomed J       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.